Recruiting
Phase 1

Alpha/Beta CD19+ Depleted Transplantation & Zometa

Sponsor:

University of Wisconsin, Madison

Code:

NCT02508038

Conditions

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Myelodysplastic Syndrome

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Interventions

TCRαβ+/CD19+ depleted Haploidentical HSCT

Zoledronate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-15. This information was provided to ClinicalTrials.gov by University of Wisconsin, Madison on 2025-10-16.